0001288123-18-000026.txt : 20181003
0001288123-18-000026.hdr.sgml : 20181003
20181003153503
ACCESSION NUMBER: 0001288123-18-000026
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181001
FILED AS OF DATE: 20181003
DATE AS OF CHANGE: 20181003
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wright Timothy
CENTRAL INDEX KEY: 0001383313
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-29089
FILM NUMBER: 181104894
MAIL ADDRESS:
STREET 1: C/O ANTIGENICS INC
STREET 2: 3 FORBES ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AGENUS INC
CENTRAL INDEX KEY: 0001098972
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 061562417
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3 FORBES ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-674-4410
MAIL ADDRESS:
STREET 1: 3 FORBES ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
FORMER COMPANY:
FORMER CONFORMED NAME: ANTIGENICS INC /DE/
DATE OF NAME CHANGE: 19991115
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2018-10-01
0
0001098972
AGENUS INC
AGEN
0001383313
Wright Timothy
C/O ANTIGENICS INC
3 FORBES ROAD
LEXINGTON
MA
02421
1
0
0
0
Deferred Shares
2.005
2018-10-01
4
A
0
3584.646
2.005
A
Common Stock
3584.646
3584.646
D
Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.
Christine M. Klaskin, by Power of Attorney
2018-10-03